Follow
Robert Zeillinger
Robert Zeillinger
Professor of Tumor Biology
Verified email at muv.ac.at - Homepage
Title
Cited by
Cited by
Year
Correlation of circular RNA abundance with proliferation–exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis and normal human tissues
A Bachmayr-Heyda, AT Reiner, K Auer, N Sukhbaatar, S Aust, ...
Scientific reports 5 (1), 8057, 2015
7402015
In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.
S Bautista, H Valles, RL Walker, S Anzick, R Zeillinger, P Meltzer, ...
Clinical cancer research: an official journal of the American Association …, 1998
3011998
Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients
R Königsberg, E Obermayr, G Bises, G Pfeiler, M Gneist, F Wrba, ...
Acta oncologica 50 (5), 700-710, 2011
2992011
Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups
F Courjal, M Cuny, J Simony-Lafontaine, G Louason, P Speiser, ...
Cancer research 57 (19), 4360-4367, 1997
2981997
Quantitative detection of reverse transcriptase-PCR products by means of a novel and sensitive DNA stain.
C Schneeberger, P Speiser, F Kury, R Zeillinger
Genome Research 4 (4), 234-238, 1995
2761995
Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors
F Courjal, G Louason, P Speiser, D Katsaros, R Zeillinger, C Theillet
International journal of cancer 69 (4), 247-253, 1996
2401996
Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer
LA Hefler, N Concin, G Hofstetter, C Marth, A Mustea, J Sehouli, ...
Clinical cancer research 14 (3), 710-714, 2008
2382008
EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients.
J Fischer-Colbrie, A Witt, H Heinzl, P Speiser, K Czerwenka, P Sevelda, ...
Anticancer research 17 (1B), 613-619, 1997
2141997
Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors in Vivo
N Concin, K Becker, N Slade, S Erster, E Mueller-Holzner, H Ulmer, ...
Cancer research 64 (7), 2449-2460, 2004
2062004
Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease‐free survival
A Obermair, E Kucera, K Mayerhofer, P Speiser, M Seifert, K Czerwenka, ...
International journal of cancer 74 (4), 455-458, 1997
2041997
Agnus castus extracts inhibit prolactin secretion of rat pituitary cells
G Sliutz, P Speiser, AM Schultz, J Spona, R Zeillinger
Hormone and metabolic research 25 (05), 253-255, 1993
1951993
HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer.
R Zeillinger, F Kury, K Czerwenka, E Kubista, G Sliutz, W Knogler, ...
Oncogene 4 (1), 109-114, 1989
1951989
Contribution of epigenetic silencing of tumor necrosis factor–related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer
P Horak, D Pils, G Haller, I Pribill, M Roessler, S Tomek, R Horvat, ...
Molecular cancer research 3 (6), 335-343, 2005
1852005
Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer
LA Hefler, R Zeillinger, C Grimm, AK Sood, WF Cheng, A Gadducci, ...
Gynecologic oncology 103 (2), 512-517, 2006
1782006
Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer
A Kafka, G Sauer, C Jaeger, R Grundmann, R Kreienberg, R Zeillinger, ...
International journal of oncology 22 (5), 1117-1121, 2003
1752003
Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients
E Obermayr, F Sanchez-Cabo, MKM Tea, CF Singer, M Krainer, ...
BMC cancer 10, 1-12, 2010
1502010
The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells
BC Schmid, GA Rezniczek, G Fabjani, T Yoneda, S Leodolter, R Zeillinger
Breast cancer research and treatment 106, 333-342, 2007
1472007
Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer
D Tong, K Czerwenka, G Heinze, M Ryffel, E Schuster, A Witt, S Leodolter, ...
Clinical Cancer Research 12 (8), 2442-2448, 2006
1452006
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance—a study of the OVCAD consortium
E Obermayr, DC Castillo-Tong, D Pils, P Speiser, I Braicu, T Van Gorp, ...
Gynecologic oncology 128 (1), 15-21, 2013
1422013
Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women
LA Hefler, C Grimm, T Lantzsch, D Lampe, S Leodolter, H Koelbl, ...
Clinical cancer research 11 (16), 5718-5721, 2005
1422005
The system can't perform the operation now. Try again later.
Articles 1–20